British Standards Institution v RRR Manufacturing Pty Ltd, R (On the Application Of)

Factual and Procedural Background

The Defendant, an approved body appointed by the national regulatory agency, suspended a certificate authorising the Appellee, a foreign company, to market a portable defibrillator device in the United Kingdom. The Appellee had previously obtained the certificate and passed required assessments. Concerns were raised by unidentified stakeholders, including individuals associated with competitors, leading to a review and identification of alleged non-conformities related to the device’s safety, clinical data, and equivalence to other devices. The Appellee challenged three related decisions of the Defendant by applying for judicial review and sought interim relief restraining the Defendant from suspending or withdrawing the certificate and requiring renewal of the certificate until the judicial review was determined. The Administrative Court Judge granted the interim relief and ordered the Defendant to pay the Appellee’s costs of the interim application. The Defendant appealed against all facets of the order, and this judgment concerns the appeal and the grant of permission to appeal.

Legal Issues Presented

1. What is the nature of the court's jurisdiction to grant interim relief on an application for judicial review, and did the Judge apply the relevant principles correctly?
2. What is the court's approach to the grant of a mandatory injunction requiring a public authority to make a particular decision, and did the Judge apply the relevant principles correctly?
3. What is the court's approach to ordering a defendant who unsuccessfully resisted interim relief to pay the costs of that application, and did the Judge apply the relevant principles correctly?

Arguments of the Parties

Defendant's Arguments

• The Judge erred in law by misunderstanding the burden of proof; the manufacturer (Appellee) must satisfy the Defendant that the device is safe and meets essential regulatory requirements, not the other way around.
• The Judge incorrectly found no evidence that the device posed a current health and safety risk; the Defendant’s concern is whether the manufacturer has shown conformity, not proving the device unsafe.
• The prior certification and allowance to sell during corrective action plans are not determinative; the Defendant conducted a detailed review and found insufficient clinical evidence to confirm safety and effectiveness.
• The Judge gave excessive weight to commercial harm and insufficient weight to public health and safety concerns and the Defendant’s regulatory role.
• The grant of a mandatory injunction compelling the Defendant to renew the certificate was legally incorrect because it requires a strong prima facie case which was not found, and courts have limited powers to direct future decisions of public authorities.
• The costs order was premature, as the overall judicial review claim had not been decided; costs should have been reserved until the final outcome.

Appellee's Arguments

• The Defendant’s appeal represents an attempt to obtain a second chance to challenge the interim relief; the Judge did not err in law.
• The requirement for a "strong prima facie case" is not a gateway test but a factor within the balance of convenience assessment.
• The Defendant unreasonably changed position, failing to provide a fair opportunity to address concerns, and there was no direct evidence that the device was unsafe.
• The central regulatory test involves a positive risk/benefit balance; it is never possible to say a device is absolutely safe or unsafe.
• The device was initially certified based on equivalence to another approved device; losing that certificate forces the manufacturer to provide its own clinical data, which is underway.
• The Judge rightly exercised equitable discretion in granting interim relief, including the mandatory order, to preserve the status quo and prevent irreparable harm to the Appellee’s business.
• The costs order was appropriate given the circumstances and the Defendant’s refusal to agree to interim relief.

Regulatory Agency's Position

• At the time of the interim relief hearing, the regulatory agency had not exercised enforcement powers but was actively reviewing the device.
• Subsequently, the agency identified potential safety and performance issues and requested a voluntary suspension of sales from the Appellee, which was refused.
• The agency intends to continue monitoring the device closely.

Table of Precedents Cited

Court's Reasoning and Analysis

The court analysed the appeal grounds by carefully applying the relevant legal principles governing interim relief in judicial review proceedings and the statutory and regulatory framework for medical devices. It distinguished the court’s jurisdiction in judicial review from a free-standing equitable jurisdiction, noting that the court applies private law principles by analogy but exercises powers under the Senior Courts Act 1981.

The court identified two key errors in the Judge’s approach to the first ground: a reversal of the burden of proof and an improper balancing of harms. The Judge wrongly required the Defendant to prove the device unsafe, whereas the manufacturer must demonstrate conformity with essential safety requirements. The Judge also gave excessive weight to commercial harm and insufficient weight to the Defendant’s legitimate regulatory concerns about insufficient clinical data and safety evidence, and to the availability of alternative certified devices.

Regarding the second ground, the court noted the novelty and legal impropriety of the Judge’s mandatory injunction compelling the Defendant to renew the certificate before any final decision on lawfulness. The court emphasised that courts have limited powers to direct future decisions of public bodies, particularly absent findings of unlawfulness and that the threshold for mandatory relief is high.

On the third ground, the court found that the Judge erred in ordering costs against the Defendant for the interim relief application before the full claim was resolved. The normal practice is to reserve costs of interlocutory applications unless exceptional circumstances justify otherwise.

The court concluded that the balance of convenience, properly assessed, favoured refusal of interim relief given the regulatory concerns and public health interest. The mandatory order was unlawful, and the costs order premature. The appeal was therefore allowed on all grounds.

Holding and Implications

The court ALLOWED THE APPEAL on all three grounds.

Consequently, the previous order granting interim relief restraining the Defendant from suspending or withdrawing the certificate, mandating renewal of the certificate pending judicial review, and ordering the Defendant to pay the Appellee’s interim costs was set aside. The decision restores the Defendant’s discretion to suspend or withdraw certification based on regulatory assessments and clarifies the limited circumstances in which courts may grant mandatory injunctions against public authorities in judicial review. No new precedent was established beyond the application of existing principles to the facts of this case. The parties’ positions revert to the status quo pending determination of the substantive judicial review claim, with the regulatory agency maintaining active review of the device’s safety and performance.